title: De novo malignant disease after liver transplantation? Risk and surveillance strategies.
authors.affiliation: Centenary Research Institute, A. W. Morrow Gastroenterology and Liver Center, Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Geoffrey W
authors.initials: GW
authors.lastname: McCaughan
authors.forename: Claire M
authors.initials: CM
authors.lastname: Vajdic
mesh_terms: D015897:Comorbidity; D005355:Fibrosis / Q000150:complications / Q000628:therapy*; D006801:Humans; D007107:Immune System / Q000473:pathology; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008108:Liver Diseases, Alcoholic / Q000150:complications; D017093:Liver Failure / Q000628:therapy*; D016031:Liver Transplantation; D008232:Lymphoproliferative Disorders / Q000209:etiology; D009369:Neoplasms / Q000209:etiology* / Q000473:pathology; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents